Recent Updates
Recently added Catalysts

Teriparatide

Phase 3

Femur Neck Fracture | Small molecule | Musculoskeletal |Eli Lilly and Company|Last Updated: Apr 16, 2015

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindPLACEBO_CONTROLLEDDMCBiomarker
Total Trials2
Total Enrollment161
FDA Designations
No designations recorded
Clinical Trials (2)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01473589Effect of Teriparatide on Hip Fracture HealingPHASE3 COMPLETED 122Feb 1, 2012Dec 1, 2013Apr 16, 201592 United States, Australia +17
NCT01473602Second Study of the Effect of Teriparatide on Hip Fracture HealingPHASE3 COMPLETED 39Jan 1, 2012Nov 1, 2013Apr 16, 201575 United States, Belgium +12
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture
12 months

Revision surgery (re-operation) was defined as any additional surgical intervention performed or recommended at the site of the index procedure, except those that were planned at the time of the index procedure.

Secondary Endpoints
Percentage of Participants With Radiographic Evidence of Healing
Randomization up to 12 months
Percentage of Participants With Pain Control During Ambulation
Up to 12 months
Percentage of Participants Without Severe Fracture-Site Pain During 24 Hours Prior to Visit
Up to 12 months
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingTRIPLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
PlaceboPLACEBO_COMPARATORAdministered once daily by subcutaneous (SC) injection for 6 months
TeriparatideEXPERIMENTAL20 microgram (µg) administered once daily by SC injection for 6 months
Interventions
NameTypeDescription
TeriparatideDRUGAdministered by SC injection
PlaceboDRUGAdministered by SC injection
Calcium supplementationDIETARY_SUPPLEMENTAdministered orally
Vitamin D supplementationDIETARY_SUPPLEMENTAdministered orally
Unlock Study Design Details
Eligibility Criteria
Age Range50 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites92

Inclusion Criteria: * Community dwelling men and postmenopausal women who were ambulatory before sustaining a low-trauma, unilateral femoral neck fracture (displaced or nondisplaced) * Other than femoral neck fracture, be free of incapacitating conditions and have a life expectancy of at least 2 ye...

Countries:United StatesAustraliaCanadaDenmarkEstoniaFinlandHong KongIndiaIsraelJapanLatviaLithuaniaNew ZealandNorwayPuerto RicoSouth KoreaSpainSwedenTaiwanBelgiumCroatiaFranceGermanyGreeceHungaryNetherlandsPolandRomaniaSwitzerlandTurkey (Türkiye)
Unlock Eligibility Criteria